Superbugs and Multiple Drug Resistance to Drive E. coli Diagnostics Testing Market to USD 1.5 Billion by 2020

Superbugs and Multiple Drug Resistance to Drive E. coli Diagnostics Testing Market to USD 1.5 Billion by 2020

E. coli Diagnostics Testing Market – Global Clinical Testing Methods Analysis and Forecast 2016-2020, estimates the global E. coli diagnostics testing market to reach nearly USD 1.5 Billion in 2020, at a CAGR of 4.6% from 2016 to 2020 – iHealthcareAnalyst, Inc.

Visit the E. coli Diagnostics Testing Market – Global Clinical Testing Methods Analysis and Forecast 2016-2020 report at https://www.ihealthcareanalyst.com/report/e-coli-testing-market/

Many bacterial infections present similar symptoms. Pathogenic E. coli represent a phenotypically diverse group of pathogens and no single method or approach can be used to detect or isolate all of the pathotypes of concern. E. coli diagnostics testing is usually conducted by an accurate history, physical exam, and analysis of the fecal sample. Other tests include PCR and immunofluorescence tests. The CDC suggests that, although the immunological test is better than bacterial culture techniques, both culture and immunological tests should be conducted at the same time. The E. coli diagnostics testing market report estimates the market size (Revenue USD million – 2013 to 2020) and composition of this market in terms of clinical testing methods and end users such as hospitals, diagnostic labs and physician office along with forecasts growth trends (CAGR% – 2016 to 2020). It also covers the major competitors operating in the market and provides a bird’s eye view of the different clinical testing methods used in the global market.

The global E. coli diagnostics testing market is segmented as:

  1. Testing Methods
    • Clinical Testing Methods
      • Polymerase Chain Reaction (PCR) Tests
      • Enzyme Immunoassays (EIA)
      • Others
  1. End User
    • Clinical Testing
      • Hospital
      • Diagnostic Laboratories
      • Physician Offices
  1. Geography (Region, Country)
    • North America (U.S., Canada)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World
  1. Company Profiles
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • CPI International, Inc.
    • Danaher Corporation
    • Ecolab, Inc.
    • EMLab P&K, LLC
    • Hoffmann-La Roche Ltd.
    • IDEXX Laboratories, Inc.
    • Meridian Bioscience, Inc.
    • Micrology Laboratories
    • NanoLogix, Inc.
    • Nelson Analytical Lab
    • Pro Lab Diagnostics, Inc.
    • Roka Bioscience, Inc.
    • Thermo Fisher Scientific, Inc.

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: [email protected]
Website: https://www.ihealthcareanalyst.com

2016-10-14T06:20:01+00:00 Categories: Press Releases|